143 related articles for article (PubMed ID: 9468734)
1. Malignant lymphoma arising from natural killer cells: report of the first case in 1970 and newer developments in the FasL-->FasR system.
Sinkovics JG
Acta Microbiol Immunol Hung; 1997; 44(3):295-303. PubMed ID: 9468734
[TBL] [Abstract][Full Text] [Related]
2. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
3. Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1999; 19(4B):3293-314. PubMed ID: 10652626
[TBL] [Abstract][Full Text] [Related]
4. Human natural killer cells: a comprehensive review.
Sinkovics JG; Horvath JC
Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
[TBL] [Abstract][Full Text] [Related]
5. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
6. Human Fas-ligand expression on porcine endothelial cells does not protect against xenogeneic natural killer cytotoxicity.
Matter-Reissmann UB; Sonntag KC; Gilli UO; Leguern C; Schneider MK; Seebach JD
Xenotransplantation; 2004 Jan; 11(1):43-52. PubMed ID: 14962292
[TBL] [Abstract][Full Text] [Related]
7. Role of nonspecific cytotoxic cells in the induction of programmed cell death of pathogenic protozoans: participation of the Fas ligand-Fas receptor system.
Jaso-Friedmann L; Leary JH; Evans DL
Exp Parasitol; 2000 Oct; 96(2):75-88. PubMed ID: 11052866
[TBL] [Abstract][Full Text] [Related]
8. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
9. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
10. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
[TBL] [Abstract][Full Text] [Related]
11. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis.
Kersemaekers AM; van Weeren PC; Oosterhuis JW; Looijenga LH
J Pathol; 2002 Apr; 196(4):423-9. PubMed ID: 11920738
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway.
Furuke K; Shiraishi M; Mostowski HS; Bloom ET
J Immunol; 1999 Feb; 162(4):1988-93. PubMed ID: 9973469
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
Li Q; Nakadai A; Takeda K; Kawada T
Toxicology; 2004 Nov; 204(1):41-50. PubMed ID: 15369847
[TBL] [Abstract][Full Text] [Related]
14. Increased Fas ligand expression by T cells and tumour cells in the progression of actinic keratosis to squamous cell carcinoma.
Satchell AC; Barnetson RS; Halliday GM
Br J Dermatol; 2004 Jul; 151(1):42-9. PubMed ID: 15270871
[TBL] [Abstract][Full Text] [Related]
15. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
16. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
17. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
Brandau S; Suttmann H; Riemensberger J; Seitzer U; Arnold J; Durek C; Jocham D; Flad HD; Böhle A
Clin Cancer Res; 2000 Sep; 6(9):3729-38. PubMed ID: 10999767
[TBL] [Abstract][Full Text] [Related]
18. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.
Contini P; Ghio M; Poggi A; Filaci G; Indiveri F; Ferrone S; Puppo F
Eur J Immunol; 2003 Jan; 33(1):125-34. PubMed ID: 12594841
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Fas ligand in normal and malignant breast epithelium does not induce apoptosis in Fas-sensitive cells.
Ragnarsson GB; Mikaelsdottir EK; Vidarsson H; Jónasson JG; Olafsdóttir K; Kristjánsdóttir K; Kjartansson J; Ogmundsdóttir HM; Rafnar T
Br J Cancer; 2000 Dec; 83(12):1715-21. PubMed ID: 11104571
[TBL] [Abstract][Full Text] [Related]
20. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.
Pitti RM; Marsters SA; Lawrence DA; Roy M; Kischkel FC; Dowd P; Huang A; Donahue CJ; Sherwood SW; Baldwin DT; Godowski PJ; Wood WI; Gurney AL; Hillan KJ; Cohen RL; Goddard AD; Botstein D; Ashkenazi A
Nature; 1998 Dec; 396(6712):699-703. PubMed ID: 9872321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]